PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Spok Holdings, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Spok Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 8.1 times. Higher than 94% of Healthcare companies in United States.
  • Debt Due Cover Ratio: Debt due within a year is covered 10.8 times by its yearly operating cash. Higher than 86% of Healthcare companies in United States.

Cash quality

Profit Cash Ratio

$181

Over the last 3 years, every $100 of reported profit came with $181 of operating cash.

Higher than 67% of Healthcare companies in United States.

Self-Funding Ratio

8.1×

Over the last 3 years its own operating cash covered its investment spending (capex) 8.1 times.

Higher than 94% of Healthcare companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

2/3 · 1/3

Sales grew in 2 of the last 3 years; profit grew in 1 of 3.

Steadier than 50% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales barely changed

Sales changed by +4% in 3 years, too little to measure extra profit per extra sales.

Asset Productivity Ratio

+4% / -16%

In 3 years sales changed by +4% while total assets changed by -16%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

10.8×

Debt due within a year is covered 10.8 times by its yearly operating cash.

Higher than 86% of Healthcare companies in United States.

Cash Cushion Ratio

+8%

Cash, after subtracting all debt, equals 8% of its market value (net cash).

Lower than 52% of Healthcare companies in United States.

Tangible Assets Ratio

52%

Of every $100 the company owns, $52 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 78% of Healthcare companies in United States.

Tangible Net Worth Ratio

32%

Of every $100 of net worth, $32 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 61% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+3%

Share count rose 3% in 3 years, so each share's slice of the company became smaller. Dividends paid equalled 170% of profit over the same period.

Smaller rise in share count than 78% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Spok Holdings, Inc. owes $0.28 for every $1 it owns. Net profit rose 6% in the year to Dec 2025, and shrank 10% a year on average over 3 years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

18.8

Investors pay $18.8 for every $1 of Spok Holdings, Inc.'s yearly profit, lower than 66% of Healthcare companies in United States.

P/B ratio

1.60

The share price is 1.60 times Spok Holdings, Inc.'s book value per share, lower than 65% of Healthcare companies in United States.

Market cap

$224 M

The total market value of all of Spok Holdings, Inc.'s shares at today's price (share price × number of shares), smaller than 57% of Healthcare companies in United States. PosiCap size class: Mini Cap.

Net worth (book value)

$140 M

What Spok Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$6.69

Net worth divided by the number of shares. The share price of $10.71 is 1.6 times this, which is the P/B above.

Return on equity (ROE)

8.4%

Spok Holdings, Inc. earned 8.4% on its shareholders' money over the last year, higher than 82% of Healthcare companies in United States.

Owes vs Owns

0.28×

Spok Holdings, Inc. owes $0.28 for every $1 it owns (low), lower than 62% of Healthcare companies in United States.

Dividend yield

12.07%

Spok Holdings, Inc. pays 12.07% of its share price as dividends a year, higher than almost all dividend-paying Healthcare companies in United States.

Revenue growth

+1%

Revenue rose 1% in the year to Dec 2025, and grew 1% a year on average over 3 years.

Profit growth

+6%

Net profit rose 6% in the year to Dec 2025, and shrank 10% a year on average over 3 years.

Profit margin

11.4%

Spok Holdings, Inc. keeps $11 of every $100 of revenue as net profit.

Cash quality

1.8×

Cash from Spok Holdings, Inc.'s business was 1.8× its reported profit in the year to Dec 2025 — its profit turned into cash.

Cash vs debt

Net cash

Spok Holdings, Inc. held $18 M more cash than debt (net cash) at Dec 2025.

Questions

What is Spok Holdings, Inc.'s P/E ratio?

Investors pay $18.8 for every $1 of Spok Holdings, Inc.'s yearly profit, lower than 66% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Spok Holdings, Inc.: $224 M ÷ $140 M (30 Jun 2026) = 1.6.

What is Spok Holdings, Inc.'s return on equity?

Spok Holdings, Inc. earned 8.4% on its shareholders' money over the last year, higher than 82% of Healthcare companies in United States.

How much does Spok Holdings, Inc. owe compared with what it owns?

Spok Holdings, Inc. owes $0.28 for every $1 it owns (low), lower than 62% of Healthcare companies in United States.

Does Spok Holdings, Inc. pay a dividend?

Yes. Spok Holdings, Inc. pays 12.07% of its share price as dividends a year, higher than almost all dividend-paying Healthcare companies in United States.

Is Spok Holdings, Inc.'s revenue growing?

Revenue rose 1% in the year to Dec 2025, and grew 1% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.